Conditions: Conjunctivitis, Allergic
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 240
Healthy volunteers: no

Brief summary:
This study will evaluate the safety and efficacy of AGN-229666 for the prevention of allergen-mediated conjunctivitis.

Detailed description:

Arms:
arm 1: One drop of AGN-229666 in each eye on Days 1 and 15. arm 2: One drop of Vehicle to AGN-229666 in each eye on Days 1 and 15. arm 3: One drop of olopatadine in each eye on Days 1 and 15. arm 4: One drop of AGN-229666 in one eye and one drop of olopatadine in the other eye on Days 1 and 15. arm 5: One drop of AGN-229666 in one eye and one drop of Vehicle to AGN-229666 in the other eye on Days 1 and 15.

Interventions: intervention 1: AGN-229666 intervention 2: Vehicle to AGN-229666 intervention 3: Olopatadine
Intervention descriptions: intervention 1: One drop of AGN-229666 in the eye on Days 1 and 15. intervention 2: One drop of Vehicle to AGN-229666 in the eye on Days 1 and 15. intervention 3: One drop of olopatadine in the eye on Days 1 and 15.

Protocol document: